US Broker Ratings

Axsome Therapeutics, Inc. (AXSM) Stock Analysis: A Promising Biotech with 18.52% Potential Upside

Axsome Therapeutics, Inc. (NASDAQ: AXSM) is making waves in the biotechnology sector, with its innovative approach to treating central nervous system (CNS) disorders. As the company continues to develop and..

Alkermes plc (ALKS) Stock Analysis: Navigating a 28% Potential Upside in the Biopharmaceutical Sector

Alkermes plc (NASDAQ: ALKS), a prominent player in the biopharmaceutical industry, presents an intriguing opportunity for investors with a substantial 28.11% potential upside based on current analyst target prices. As..

AptarGroup, Inc. (ATR) Stock Analysis: Exploring a Potential 24.56% Upside in the Healthcare Sector

AptarGroup, Inc. (NYSE: ATR) presents a compelling opportunity in the healthcare sector, specifically within the medical instruments and supplies industry. With a market capitalization of $8.41 billion, AptarGroup stands out..

Exelixis, Inc. (EXEL) Stock Analysis: A Biotech Leader with Strong Growth Potential and 4.33% Upside

Exelixis, Inc. (NASDAQ: EXEL), a prominent player in the biotechnology sector, is drawing attention from investors seeking robust growth opportunities in the healthcare industry. With a market capitalization of $11.66..

Medpace Holdings, Inc. (MEDP) Stock Analysis: Steady Growth with Strategic Insights

Medpace Holdings, Inc. (NASDAQ: MEDP), a prominent player in the healthcare sector, stands out for its robust service offerings in diagnostics and research. With a market capitalization of $14.87 billion,..

Insmed Incorporated (INSM) Stock Analysis: Potential 47% Upside with Strong Buy Ratings

Investors looking to navigate the volatile seas of biotechnology have a compelling opportunity in Insmed Incorporated (NASDAQ: INSM), a company that has garnered unanimous bullish sentiment from analysts. Specializing in..

Molina Healthcare Inc (MOH) Stock Analysis: Navigating a Stable Course with Modest Upside

Molina Healthcare Inc (NYSE: MOH), a prominent player in the healthcare plans industry, is a company worth a closer look for investors interested in the healthcare sector. With a market..

Teleflex Incorporated (TFX) Stock Analysis: A Healthcare Player with Steady Prospects

Teleflex Incorporated (NYSE: TFX), a prominent player in the medical instruments and supplies industry, has been attracting attention from investors due to its solid presence in the healthcare sector. With..

Elanco Animal Health (ELAN): Investor Outlook on Strong Buy Ratings and Robust Growth Potential

Elanco Animal Health Incorporated (NYSE: ELAN) is capturing investor attention with its strong buy ratings and substantial growth potential, reflecting a promising outlook for the company. With a market capitalization..

Moderna, Inc. (MRNA) Investor Outlook: Assessing the Biotech Giant Amidst Revenue Decline and Market Volatility

Moderna, Inc. (NASDAQ: MRNA) has made headlines since the onset of the COVID-19 pandemic, leveraging its mRNA technology to become a household name. However, as the pandemic’s urgency wanes, the..

Revvity, Inc. (RVTY) Stock Analysis: Navigating a 22.53% Upside Potential in the Healthcare Diagnostics Sector

Revvity, Inc. (RVTY), a notable player in the healthcare diagnostics and research sector, presents a compelling opportunity for investors seeking exposure to the healthcare industry. With its recent rebranding from..

BioNTech SE (BNTX) Stock Analysis: Navigating Challenges with a 28.64% Potential Upside

BioNTech SE (NASDAQ: BNTX), a recognized leader in biotechnology based in Germany, has been making waves in the healthcare sector with its pioneering work in immunotherapy and mRNA technology. With..

HealthEquity, Inc. (HQY) Investor Outlook: 31% Upside Potential Drives Strong Buy Ratings

HealthEquity, Inc. (NASDAQ: HQY), a leader in the Health Information Services industry, is capturing investor attention with its promising growth potential and dominant position in the healthcare sector. With a..

Henry Schein, Inc. (HSIC) Stock Analysis: Exploring a 14.17% Potential Upside in the Healthcare Sector

Henry Schein, Inc. (NASDAQ: HSIC), a stalwart in the healthcare sector, is capturing investor attention with its robust market position and potential for a 14.17% upside. As a leading provider..

Biogen Inc. (BIIB) Stock Analysis: Navigating a 17% Potential Upside Amidst Market Challenges

Biogen Inc. (BIIB), a prominent player in the healthcare sector, stands out in the drug manufacturing industry despite facing recent headwinds. With a market capitalization of $26.03 billion, Biogen is..

Avantor, Inc. (AVTR) Stock Analysis: Evaluating Growth Potential Amid a 24.14% Upside

Avantor, Inc. (NYSE: AVTR), a prominent player in the healthcare sector, is capturing investor attention with its potential upside of 24.14%, as suggested by analysts’ target prices. This potential growth..

Chemed Corp (CHE) Stock Analysis: Evaluating a 15% Growth Potential Amidst Stable Healthcare Services

Investors looking to explore opportunities in the healthcare sector might find Chemed Corp (NYSE: CHE) an intriguing prospect. With its diverse business operations spanning hospice care and plumbing services, Chemed..

Summit Therapeutics Inc. (SMMT): Investor Outlook on This Biotech Stock with 23.70% Potential Upside

Summit Therapeutics Inc. (NASDAQ: SMMT) has caught the attention of investors in the biotech sector, thanks to its promising pipeline and potential upside of 23.70%. Let’s delve into the various..

Stevanato Group S.p.A. (STVN) Stock Analysis: Unveiling a 59% Potential Upside for Investors

For investors with an eye on the healthcare sector, Stevanato Group S.p.A. (NYSE: STVN) offers a compelling opportunity. With its strategic position in the medical instruments and supplies industry, this..

Regencell Bioscience Holdings (RGC) Stock Analysis: Navigating the Volatility with a 52-Week Range from $0.76 to $78.00

Regencell Bioscience Holdings Limited (NASDAQ: RGC), a Hong Kong-based company specializing in Traditional Chinese Medicine (TCM), has captured the attention of investors with its dramatic 52-week price range spanning from..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds